Algeria

We have a long heritage in Algeria - where we have been operating for 35 years - to bring our innovative medicines, vaccines and consumer healthcare products to those who need them. Algeria is our second largest subsidiary in the Middle East.

Our Algerian business is a locally integrated company, with significant investments in the country, and is one of the first and largest foreign direct investments in the sector in Algeria. We have been consistently building local presence investing in local manufacturing in line with the Algerian government’s desire to build local pharmaceutical manufacturing capability.  Currently, GSK employs more than 450 people in Algeria across manufacturing, distribution, sales and marketing. Our investment includes dedicated antibiotic and non-antibiotic local manufacturing facilities where we produce around 70 million units a year, comprising around 50% of our portfolio in Algeria, as well as one national distribution centre.

So what does this mean for you?

We have the Commercial Management (Pharmaceuticals) career path available in Algeria.

Programmes available in Algeria